June 18, 2021
Article
May 20, 2021
Study finds communicating on Electronic Medical Record (EMR) led to follow-up with infectious disease providers.
May 07, 2021
Machine learning improves prediction of bacterial sepsis among immunocompromised recipients of stem cell transplant.
April 15, 2021
March 02, 2021
Investigational therapy, ibrexafungerp, from Scynexis is being studied for fungal infections and is moving closer towards a goal of FDA approval later this year.
February 08, 2021
Implications for antimicrobial use and antimicrobial resistance.
February 01, 2021
A £100 million donation from Ineos will fund collaborative effort across sciences.
December 16, 2020
Video
In a mature market of agents, the investigational therapy, ibrexafungerp, from Scynexis is looking at a few antifungal indications with a potential FDA approval in 2021.
November 17, 2020
More than 13 million children did not receive their first DTP vaccine dose in 2019—and investigators anticipate the 2020 rate will be worse.
October 25, 2020
New data may evidence oral care as a therapeutic measure to reduce bacterial and viral spread.
